Dietary Approach to Improving Quality of Life in Amyotrophic Lateral Sclerosis
NCT03659422 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-06-14
Summary
We have had reports of an individual who utilized a modified Paleolithic diet and vitamin/ supplement program as part of his approach to managing ALS related symptoms. This individual has experienced stability in his ALS functional rating score and stable to improving strength over an 18 month period. There are also anecdotal reports of ALS patients who have utilized a dietary approach based on a Paleolithic eating plan of improved function. This is a safety study. We will be assessing if patients can implement the proposed modified Paleolithic diet (Wahls Elimination), if lean muscle mass is maintained on the study diet, and what changes occur in the ALS functional symptoms and quality of life.
Conditions
- Diet Modification
- Amyotrophic Lateral Sclerosis
Interventions
- OTHER
-
Modified Paleolithic diet
The diet eliminates legumes, grains and nightshades (as opposed to the Paleolithic diet) and is higher in vegetable and fruit intake and in omega-3 fatty rich foods.
Sponsors & Collaborators
-
Muscular Dystrophy Association
collaborator OTHER -
Terry L. Wahls
lead OTHER
Principal Investigators
-
Terry L Wahls, MD · University of Iowa
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2021-07-01
- Completion
- 2021-07-01
More Related Trials
-
Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation
NCT00116558 ·Status: COMPLETED ·Phase: NA
-
Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients
NCT03326622 ·Status: COMPLETED ·Phase: NA
-
Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype
NCT01823380 ·Status: COMPLETED ·Phase: NA
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)
NCT02572479 ·Status: COMPLETED
-
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01933321 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
DIAGALS: Relation Between Tar DNA Binding Protein(TDP)-43 et Nrf-2 in ALS: a Track to Improve Diagnosis and Prognosis of the Disease
NCT06230562 ·Status: UNKNOWN ·Phase: NA
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
NCT01082653 ·Status: SUSPENDED ·Phase: PHASE1
-
Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)
NCT01016522 ·Status: TERMINATED ·Phase: PHASE3
-
potentiALS - Quality of Life Among Patients With Amyotrophic Lateral Sclerosis
NCT06441448 ·Status: RECRUITING
-
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
NCT00983983 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 ·Status: COMPLETED
-
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 ·Status: COMPLETED
-
A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS
NCT03324399 ·Status: COMPLETED ·Phase: NA
-
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
NCT01592084 ·Status: COMPLETED
-
Examining Interactions Between PALS and Caregivers
NCT06819124 ·Status: RECRUITING ·Phase: NA
-
The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
NCT00160004 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Clinical Trial of High Dose CoQ10 in ALS
NCT00243932 ·Status: COMPLETED ·Phase: PHASE2
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420 ·Status: RECRUITING
-
Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT02588807 ·Status: WITHDRAWN ·Phase: PHASE1
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT01142856 ·Status: COMPLETED ·Phase: PHASE1